10-Q Filing

Dominari Holdings Inc. CIK: 12239 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001213900-22-071189`
Period End Date	20220930
Filing Date	20221110
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	f10q0922_aikidopharm_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 67 Cash Flow Statement 88 Stockholders Equity 32

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`RestrictedCashCurrent`	$34.50M	USD	Point-in-time
Cash and cash equivalents	`RestrictedCashCurrent`	$65.56M	USD	Point-in-time
Marketable securities	`MarketableSecurityCurrent`	$8.03M	USD	Point-in-time
Marketable securities	`MarketableSecurityCurrent`	$11.43M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$693.00K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$442.00K	USD	Point-in-time
Short-term investments at fair value	`ShortTermInvestments`	$2.27M	USD	Point-in-time
Short-term investments at fair value	`ShortTermInvestments`	$33.00K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Notes receivable at fair value	`NotesReceivableRelatedPartiesCurrent`	$8.64M	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Notes receivable at fair value	`NotesReceivableRelatedPartiesCurrent`	$6.98M	USD	Point-in-time
Deposits	`DepositsAssetsCurrent`	$4.20M	USD	Point-in-time
Deposits	`DepositsAssetsCurrent`	$4.19M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$56.09M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$90.89M	USD	Point-in-time
Convertible note receivable at fair value	`NotesReceivableRelatedPartiesNoncurrent`	-	USD	Point-in-time
Convertible note receivable at fair value	`NotesReceivableRelatedPartiesNoncurrent`	$2.15M	USD	Point-in-time
Notes receivable at fair value	`NotesReceivableRelatedParties`	$1.10M	USD	Point-in-time
Notes receivable at fair value	`NotesReceivableRelatedParties`	-	USD	Point-in-time
Investments	`Investments`	$9.46M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investments	`Investments`	$26.09M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$708.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	5.28M	shares	Point-in-time
Security deposit	`SecurityDeposit`	$458.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	5.49M	shares	Point-in-time
Security deposit	`SecurityDeposit`	$155.00K	USD	Point-in-time
Total assets	`Assets`	$102.66M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	5.28M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	5.14M	shares	Point-in-time
Total assets	`Assets`	$84.45M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockShares`	0.00	shares	Point-in-time
Treasury stock, at cost	`TreasuryStockShares`	344,982.00	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$518.00K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$381.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$680.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$1.34M	USD	Point-in-time
Lease liability - current	`FinanceLeaseLiabilityCurrent`	$42.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.90M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.06M	USD	Point-in-time
Lease liability	`FinanceLeaseLiabilityNoncurrent`	$701.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$2.60M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.06M	USD	Point-in-time
Preferred stock, $.0001 par value, 50,000,000 Authorized	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.0001 par value, 50,000,000 Authorized	`PreferredStockValue`	-	USD	Point-in-time
Series D: 5,000,000 shares designated; 3,825 shares issued and outstanding at September 30, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueOne`	-	USD	Point-in-time
Series D: 5,000,000 shares designated; 3,825 shares issued and outstanding at September 30, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueOne`	-	USD	Point-in-time
Series D-1: 5,000,000 shares designated; 834 shares issued and outstanding at September 30, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueTwo`	-	USD	Point-in-time
Series D-1: 5,000,000 shares designated; 834 shares issued and outstanding at September 30, 2022 and December 31, 2021; liquidation value of $0.0001 per share	`PreferredStockValueTwo`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 5,485,096 and 5,275,329 shares issued at September 30, 2022 and December 31, 2021, respectively; 5,140,114 and 5,275,329 shares outstanding at September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 5,485,096 and 5,275,329 shares issued at September 30, 2022 and December 31, 2021, respectively; 5,140,114 and 5,275,329 shares outstanding at September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$265.63M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$262.97M	USD	Point-in-time
Treasury stock, at cost, 344,982 and 0 shares at September 30, 2022 and December 31, 2021, respectively	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Treasury stock, at cost, 344,982 and 0 shares at September 30, 2022 and December 31, 2021, respectively	`TreasuryStockValue`	$2.50M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-163.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-178.62M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$81.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$29.62M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$103.08M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$87.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$103.17M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$101.59M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$102.66M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$84.45M	USD	Point-in-time

Income Statement 67 line items

Line Item	Tag	Value	Unit	Period
Basic and Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-1.17	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-1.14	USD	3 Qtrs
Basic and Diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-3.59	USD	3 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$5.23M	USD	3 Qtrs
Basic and Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.28M	shares	3 Qtrs
Basic and Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	4.70M	shares	3 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$8.56M	USD	3 Qtrs
Basic and Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.34M	shares	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$1.68M	USD	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.27M	shares	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$4.51M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$100.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$61.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$497.00K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.11M	USD	3 Qtrs
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$525.00K	USD	3 Qtrs
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$525.00K	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$3.00K	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$1.13M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$6.86M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$11.20M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$5.10M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.78M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.78M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-11.20M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-6.86M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.10M	USD	1 Quarter
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	$135.00K	USD	3 Qtrs
Other income	`OtherIncome`	$64.00K	USD	3 Qtrs
Interest income	`InterestIncomeExpenseNet`	$187.00K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$107.00K	USD	3 Qtrs
Interest income	`InterestIncomeExpenseNet`	$586.00K	USD	3 Qtrs
Interest income	`InterestIncomeExpenseNet`	$40.00K	USD	1 Quarter
Loss on marketable securities	`MarketableSecuritiesGainLoss`	$-2.57M	USD	3 Qtrs
Loss on marketable securities	`MarketableSecuritiesGainLoss`	$-3.03M	USD	1 Quarter
Loss on marketable securities	`MarketableSecuritiesGainLoss`	$-4.39M	USD	3 Qtrs
Loss on marketable securities	`MarketableSecuritiesGainLoss`	$-1.65M	USD	1 Quarter
Change in fair value of investments	`GainLossOnInvestments`	$3.83M	USD	3 Qtrs
Change in fair value of investments	`GainLossOnInvestments`	$4.72M	USD	1 Quarter
Change in fair value of investments	`GainLossOnInvestments`	$329.00K	USD	1 Quarter
Change in fair value of investments	`GainLossOnInvestments`	$91.00K	USD	3 Qtrs
Total other (expenses) income	`OtherNonoperatingIncomeExpense`	$1.50M	USD	3 Qtrs
Total other (expenses) income	`OtherNonoperatingIncomeExpense`	$1.73M	USD	1 Quarter
Total other (expenses) income	`OtherNonoperatingIncomeExpense`	$-3.65M	USD	3 Qtrs
Total other (expenses) income	`OtherNonoperatingIncomeExpense`	$-1.14M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-47.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.36M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-14.85M	USD	3 Qtrs
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`PreferredStockDividendsAndOtherAdjustments`	-	USD	1 Quarter
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`PreferredStockDividendsAndOtherAdjustments`	-	USD	3 Qtrs
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`PreferredStockDividendsAndOtherAdjustments`	$4.11M	USD	3 Qtrs
Net Loss Attributable to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-47.00K	USD	1 Quarter
Net Loss Attributable to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-5.36M	USD	3 Qtrs
Net Loss Attributable to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-18.96M	USD	3 Qtrs
Net Loss Attributable to Common Shareholders	`NetIncomeLossAvailableToCommonStockholdersDiluted`	$-6.24M	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasic`	$-3.59	USD	3 Qtrs
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasic`	$-1.14	USD	3 Qtrs
Basic and Diluted (in Dollars per share)	`EarningsPerShareBasic`	$-1.17	USD	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	5.28M	shares	3 Qtrs
Basic and Diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	4.70M	shares	3 Qtrs
Basic and Diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	5.34M	shares	1 Quarter
Basic and Diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	5.27M	shares	1 Quarter

Cash Flow Statement 88 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-47.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.36M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-14.85M	USD	3 Qtrs
Amortization of right-of-use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$23.00K	USD	3 Qtrs
Change in fair value of short-term investment	`ChangeInFairValueOfInvestments`	$-3.83M	USD	3 Qtrs
Change in fair value of short-term investment	`ChangeInFairValueOfInvestments`	$1.52M	USD	3 Qtrs
Change in fair value of long-term investment	`ChangeInFairValueOfLongtermInvestment`	-	USD	3 Qtrs
Change in fair value of long-term investment	`ChangeInFairValueOfLongtermInvestment`	$-1.61M	USD	3 Qtrs
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$525.00K	USD	3 Qtrs
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$1.13M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$314.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.48M	USD	3 Qtrs
Realized loss (gain) on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-712.00K	USD	3 Qtrs
Realized loss (gain) on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-144.00K	USD	1 Quarter
Realized loss (gain) on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$501.00K	USD	3 Qtrs
Realized loss (gain) on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-583.00K	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-3.89M	USD	3 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-4.30M	USD	3 Qtrs
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-2.90M	USD	1 Quarter
Unrealized loss on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-1.59M	USD	1 Quarter
Realized gain on sale of digital currencies	`GainLossOnSaleOfOtherAssets`	-	USD	3 Qtrs
Realized gain on sale of digital currencies	`GainLossOnSaleOfOtherAssets`	-	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$429.00K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$344.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$137.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$5.00K	USD	3 Qtrs
Accrued salaries and benefits	`IncreaseDecreaseInAccruedSalaries`	$-73.00K	USD	3 Qtrs
Accrued salaries and benefits	`IncreaseDecreaseInAccruedSalaries`	$659.00K	USD	3 Qtrs
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$12.00K	USD	3 Qtrs
Interest receivable on convertible note	`IncreaseDecreaseInNotesReceivables`	$107.00K	USD	3 Qtrs
Interest receivable on convertible note	`IncreaseDecreaseInNotesReceivables`	$586.00K	USD	3 Qtrs
Deposits	`IncreaseDecreaseInSecurityDeposits`	$-295.00K	USD	3 Qtrs
Deposits	`IncreaseDecreaseInSecurityDeposits`	-	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.55M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.73M	USD	3 Qtrs
Purchase of marketable securities	`PurchaseOfMarketableSecurities`	$27.48M	USD	3 Qtrs
Purchase of marketable securities	`PurchaseOfMarketableSecurities`	$90.54M	USD	3 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$28.50M	USD	3 Qtrs
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$30.44M	USD	3 Qtrs
Proceeds from sale of digital currencies	`ProceedsFromSaleOfDigitalCurrencies`	$93.00K	USD	3 Qtrs
Proceeds from sale of digital currencies	`ProceedsFromSaleOfDigitalCurrencies`	-	USD	3 Qtrs
Proceeds from sale of DatChat common shares	`ProceedsFromSaleOfDatChatCommonShares`	$900.00K	USD	3 Qtrs
Proceeds from promissory note receivable interest received	`ProceedsFromSaleAndCollectionOfNotesReceivable`	-	USD	3 Qtrs
Proceeds from promissory note receivable interest received	`ProceedsFromSaleAndCollectionOfNotesReceivable`	$65.00K	USD	3 Qtrs
Funds to deposit accounts, net	`ProceedFromFundsToDepositAccountsNet`	$-4.42M	USD	3 Qtrs
Funds to deposit accounts, net	`ProceedFromFundsToDepositAccountsNet`	-	USD	3 Qtrs
Purchase of short-term and long-term investments	`PaymentsToAcquireInvestments`	$4.07M	USD	3 Qtrs
Purchase of short-term and long-term investments	`PaymentsToAcquireInvestments`	$15.02M	USD	3 Qtrs
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	$597.00K	USD	3 Qtrs
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	$525.00K	USD	3 Qtrs
Purchase of short-term and long-term promissory notes	`PurchaseOfShorttermAndLongtermPromissoryNotes`	$1.60M	USD	3 Qtrs
Purchase of short-term and long-term promissory notes	`PurchaseOfShorttermAndLongtermPromissoryNotes`	-	USD	3 Qtrs
Purchase of convertible note	`PurchaseOfConvertibleNote`	-	USD	3 Qtrs
Purchase of convertible note	`PurchaseOfConvertibleNote`	$2.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-70.28M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-15.96M	USD	3 Qtrs
Proceeds from issuance of common stock and warrants, net of offering cost	`ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost`	$77.99M	USD	3 Qtrs
Proceeds from issuance of common stock and warrants, net of offering cost	`ProceedsFromIssuanceCommonStockAndWarrantsNetOfOfferingCost`	-	USD	3 Qtrs
Proceeds from issuance of Series O and Series P Redeemable Convertible Preferred Stock, net of discount and offering cost	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	3 Qtrs
Proceeds from issuance of Series O and Series P Redeemable Convertible Preferred Stock, net of discount and offering cost	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$17.89M	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$84.00K	USD	3 Qtrs
Payment for fractional shares	`PaymentForFractionalShares`	$26.00K	USD	3 Qtrs
Payment for fractional shares	`PaymentForFractionalShares`	-	USD	3 Qtrs
Redemption of Series O and Series P Redeemable Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	-	USD	3 Qtrs
Redemption of Series O and Series P Redeemable Convertible Preferred Stock	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$-22.00M	USD	3 Qtrs
Purchase of treasury stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Purchase of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$2.24M	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$78.07M	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.37M	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$3.23M	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-31.07M	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.50M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$65.56M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.71M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.50M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$65.56M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.71M	USD	Point-in-time
Transfer from short-term investment to marketable securities	`TransferFromShorttermInvestmentToMarketableSecurities`	$1.50M	USD	3 Qtrs
Transfer from short-term investment to marketable securities	`TransferFromShorttermInvestmentToMarketableSecurities`	-	USD	3 Qtrs
Reclassify from convertible note receivable to notes receivable at fair value	`ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue`	$2.15M	USD	3 Qtrs
Reclassify from convertible note receivable to notes receivable at fair value	`ReclassifyFromConvertibleNoteReceivableToNotesReceivableAtFairValue`	-	USD	3 Qtrs
Promissory convertible note receivable conversion into common shares	`PromissoryConvertibleNoteReceivableConversionIntoCommonShares`	-	USD	3 Qtrs
Promissory convertible note receivable conversion into common shares	`PromissoryConvertibleNoteReceivableConversionIntoCommonShares`	$899.00K	USD	3 Qtrs
Unpaid investment	`NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1`	$1.00M	USD	3 Qtrs

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Net of offering costs	`WarrantNetOfferingCosts`	$8.26M	USD	3 Qtrs
Balance	`StockholdersEquity`	$81.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.08M	USD	Point-in-time
Balance	`StockholdersEquity`	$87.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$101.59M	USD	Point-in-time
Issuance of Series O redeemable convertible preferred stock for cash	`StockIssuedDuringPeriodValueNewIssues`	-	USD	3 Qtrs
Issuance of Series P redeemable convertible preferred stock for cash	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	-	USD	3 Qtrs
Cost on issuance of Series O and Series P Redeemable Convertible Preferred Stock	`StockIssuedDuringPeriodValueOther`	-	USD	3 Qtrs
Deemed dividends related to Series O and Series P Redeemable Convertible Preferred Stock	`StockIssuedDuringPeriodValueConversionOfUnits`	$-4.11M	USD	3 Qtrs
Purchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$2.24M	USD	3 Qtrs
Purchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$751.00K	USD	1 Quarter
Issuance of common stock and warrants (net of offering costs of $8,260)	`StockIssuedDuringPeriodValueOfCommonStockAndWarrants`	$77.99M	USD	3 Qtrs
Exercise of warrants	`StockIssuedDuringPeriodValueStockOptionsExercised`	$84.00K	USD	3 Qtrs
Issuance of common stock for research and development license acquired	`StockIssuedDuringPeriodValueIssuedForResearchAndDevelopmentLicenseAcquired`	$531.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition`	$1.37M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition`	$314.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition`	$1.48M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition`	$139.00K	USD	1 Quarter
Cancellation of common stock related to investment in CBM	`DistributionOfHothCommonStock`	-	USD	3 Qtrs
Fractional shares adjusted for reverse split	`AdjustmentsToAdditionalPaidInCapitalStockSplit`	$-26.00K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-47.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.36M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-14.85M	USD	3 Qtrs
Balance	`StockholdersEquity`	$81.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$29.62M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.08M	USD	Point-in-time
Balance	`StockholdersEquity`	$87.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$103.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$101.59M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.